缺铁导致心力衰竭:以韩国为导向的综述
Ewa A Jankowska1,2, Piotr Ponikowski1,2
1Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.
International journal of heart failure
|November 8, 2023
概括
缺铁 (ID) 在心力衰竭 (HF) 患者中很常见,并使结果恶化. 及时诊断和用静脉注射铁的治疗,如铁性碳酸 (FCM),可以改善生活质量并减少住院治疗.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 公共卫生 公共卫生
背景情况:
- 缺铁 (ID) 在心力衰竭 (HF) 患者中很普遍,影响严重程度和结果.
- 智障症加剧了运动能力的降低,降低了生活质量 (QoL),并增加了HF住院风险.
- 识别障碍对公众健康和经济造成重大负担,特别是在亚洲.
研究的目的:
- 突出在亚洲心力衰竭患者中识别和治疗铁缺乏症的重要性.
- 审查ID的HF患者的诊断生物标志物和有效的静脉铁治疗方法.
- 讨论心力衰竭中静脉注射铁疗法的益处和建议.
主要方法:
- 对用于ID诊断的生物标志物的审查 (血清费里丁,转激素和).
- 对静脉注射铁疗法 (铁性碳酸,铁性脱硫酸) 的有效性和耐受性的评估.
- 对表分析的分析,支持在ID的HF患者中静脉注射铁的益处.
主要成果:
- 静脉注射铁治疗,特别是铁性碳酸盐 (FCM),在ID的HF患者中显示出有效性和耐受性.
- FCM具有成本效益,并与改善QoL和减少HF住院病例有关.
- 欧洲心脏病学会的指导方针建议在ID的症状性HF患者中考虑静脉注射FCM.
结论:
- 在HF患者,尤其是亚洲患者中,及时识别和治疗ID至关重要.
- 静脉注射铁疗法,特别是FCM,为ID的HF患者提供了显著的好处.
- 对亚洲人群进行进一步的研究是有必要的,尽管预计益处将与白人人口的益处相似.
相关概念视频
Heart Failure I: Introduction
14
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
14
Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
Heart Failure VII: Nursing Interventions
85
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
85
Heart Failure IV: Classification and Diagnostic Evaluation
17
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
17
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure V: Medical Management
9
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9


